In the current month, XRTX has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. XRTX average Analyst price target in the last month is 70.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
Strong Buy
0
0
0
0
0
0
0
0
Buy
0
0
1
1
1
1
1
1
Hold
0
0
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
0
0
1
1
1
1
1
1
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
Forecast
--
--
--
Actual
-0.45
-2.90
-1.05
Surprise
--
--
--
FAQs
What is XORTX Therapeutics Inc's price target?
Analysts forecast that XORTX Therapeutics Inc's price target is USD 14.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 14.00.
What is the analyst rating for XORTX Therapeutics Inc?
Based on the ratings of XORTX Therapeutics Inc's stock from 0 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.